ICD-10-CM Billable Code

N04.7

Nephrotic syndrome with diffuse crescentic glomerulonephritis

Clinical Classification Guidelines

Inclusion Terms

  • Nephrotic syndrome with extracapillary glomerulonephritis

Medical Intelligence & Overview

Nephrotic syndrome with diffuse crescentic glomerulonephritis is a serious kidney disorder characterized by significant protein loss in the urine and rapid damage to the kidney's filtering units. This condition involves inflammation and proliferation within the glomeruli — the tiny filtering structures in the kidneys — which leads to decreased kidney function and potential progression to kidney failure. Recognizing and understanding the signs and causes of this condition is vital for seeking timely medical attention.

Causes & Symptoms

Clinical Causes: Autoimmune diseases, such as systemic lupus erythematosus Vasculitis affecting blood vessels in the kidneys Certain infections, like hepatitis B or C Idiopathic (unknown) causes Drug-induced reactions or adverse effects Other glomerular diseases leading to inflammation and crescent formation

Key Symptoms: Swelling (edema), particularly around the eyes, feet, and abdomen Foamy or frothy urine due to high protein content Unintended weight gain from fluid retention Fatigue and weakness Decreased urine output or dark-colored urine High blood pressure in some cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of medical history, physical examination, laboratory tests, and kidney biopsy. Important diagnostic steps include: - Urinalysis showing high protein levels and possible blood in urine - Blood tests indicating decreased kidney function and abnormal levels of cholesterol, albumin, and waste products - Kidney biopsy revealing the presence of crescent-shaped scars and extracapillary glomerulonephritis, which confirms the diagnosis These tests help determine the underlying cause and guide appropriate management strategies.

Treatment Protocols: Treatment aims to control the underlying inflammation, reduce symptoms, prevent complications, and preserve kidney function. Common approaches include: - Corticosteroids to suppress immune responses - Immunosuppressive medications, such as cyclophosphamide or azathioprine - Blood pressure control using ACE inhibitors or ARBs, which also help reduce protein loss - Diuretics for managing edema - Dietary modifications, including reduced salt and protein intake - Regular monitoring of kidney function and protein levels In some cases, more advanced interventions like plasma exchange or dialysis may be necessary if kidney failure develops. Early diagnosis and intervention are crucial to improve outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N04.7 a billable ICD-10 code?
Yes, N04.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N04.7?
Clinical documentation must specify the nature of Nephrotic syndrome with diffuse crescentic glomerulonephritis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

crescentic glomerulonephritis syndrome diffuse nephrotic